定 價：99 元
叢書名：“一帶一路”背景下國際化醫(yī)學(xué)人才培養(yǎng)叢書
- 作者：韓星敏，王榮福，楊愛民 編
- 出版時間：2019/9/1
- ISBN：9787564564681
- 出 版 社：鄭州大學(xué)出版社
- 中圖法分類：R81
- 頁碼：262
- 紙張：膠版紙
- 版次：1
- 開本：16開
《核醫(yī)學(xué)（英文版）》重點(diǎn)介紹和闡述了核醫(yī)學(xué)及其相關(guān)知識的基本概念，核醫(yī)學(xué)儀器和藥物的質(zhì)量控制，臨床常規(guī)診治的輻射劑量和放射衛(wèi)生防護(hù)監(jiān)測核醫(yī)學(xué)體內(nèi)、體外檢查的原理、方法和臨床意義核素體內(nèi)、體外治療的原理和臨床應(yīng)用，突出了對于核素治療后出現(xiàn)的臨床表現(xiàn)的醫(yī)學(xué)認(rèn)識。
Chapter 1 Introduction
1．1 Basic concepts and classification of nuclear medicine
1．2 Principle of functional imaging in nuclear medicine and comparison with other imagitechniques
1．3 The history and present situation of nuclear medicine
Chapter 2 Physical Basics of Nuclear Medicine
2．1 Atomic nucleus
2．2 Radionuclides
2．3 Nuclear decay
2．4 Interaction of radioactive ray with matter
2．5 Nuclear reactions
Chapter 3 Nuclear Medicine Imaging Devices
3．1 Gamma camera and SPECT systems
3．2 PET systems
3．3 Non-Imaging detectors and counters
Chapter 4 Radiopharmaceuticals
4．1 Introduction
4．2 Manufacture of radionuclide for radiopharmaceutical
4．3 Radio pharmaceuticals
4．4 Quality control
4．5 Tendency of radio pharmaceutical
Chapter 5 Radiation Protection and Safety in Nuclear Medicine
5．1 Dose quantities and units
5．2 The principles of radiation protection
5．3 Radiation safety of the patients
5．4 Radiation protection and safety of the public
5．5 Radiation protection and safety of occupational workers
Chapter 6 In Vitro Immunoassay
6．1 Radioimmunoassay
6．2 Immunoradiometric assay
6．3 Non-radiolabeled immunoassy
6．4 Analytical quality control in radioanalytical laboratories
6．5 The clinical application of in vitro immunoassay
Chapter 7 Molecular Imaging
7．1 Conception and principle of molecular imaging
7．2 Contents of molecular imaging
7．3 Multimodality imaging
7．4 Application of molecular imaging
Chapter 8 Nuclear Neurology
8．1 Introduction
8．2 Cerebral blood flow perfusion tomography and local cerebral blood flow measurement \"
8．3 Cerebral metabolic imaging
8．4 Neuroreceptor imaging
8．5 Radionuclide cerebrovascular imaging
8．6 Cerebrospinal fluid imaging
Chapter 9 Endocrine System
9．1 Thyroid
9．2 Parathyroid
9．3 Adrenal medullary imaging
Chapter 10 Cardiovascular System
10．1 Myocardial perfusion imaging
10．2 Assessment of ventricular function
10．3 Heart failure and assessment of viability
Chapter 11 Pulmonary Imaging
11．1 Pulmonary ventilation/perfusion scintigraphy
11．2 Clinical applications
11．3 Other imaging methods
Chapter 12 Gastrointestinal System
12．1 Gastrointestinal bleeding scintigraphy
12．2 Heterotopic gastric mueosa seintigraphy
12．3 Gastroesophageal reflux scintigraphy
12．4 Gastric emptying scintigraphy
12．5 99mTe-labelled red blood cells liver seintigraphy
12．6 Liver and spleen colloid imaging
12．7 Salivary gland imaging
12．8 Urea breath test for Helicobacter pylori
12．9 Hepatobiliary dynamic imaging
Chapter 13 Urinary System
13．1 Renal anatomy
13．2 Function
13．3 Renal radiopharmaceutieals
13．4 Dynamic renal imaging techniques
13．5 Measuring renal function ： effective renal plasma flow （REPF） and glomerular filtrationrate （GFR）
13．6 Renal cortical imaging
13．7 Radionuclide eystography
13．8 Clinical applications of renal seintigraphy
Chapter 14 Skeletal System
14．1 Introduction
14．2 Anatomy and physiology
14．3 The bone scan
14．4 The joint scan
14．5 Normal appearances
14．6 Abnormal bone and joint imaging
14．7 Extra skeletal imaging agent concentration
14．8 Clinical applications of bone and joint imaging
Chapter 15 Hematology and Iymphatic System
15．1 Bone marrow scintigraphy
15．2 Spleen imaging
15．3 Lymphoscintigraphy
Chapter 16 Tumor Imaging
16．1 Introduction
16．2 JSF-FDG PET/CT imaging
16．3 Tumor imaging with other positron-emitting agents but ISF-FDG
16．4 SPECT and SPECT/CT imaging in tumor
Chapter 17 Inflammation Imaging
17．1 Gallium-67 citrate scan
17．2 Radiolabeled leukocytes scan
17．3 18F-FDG PET/CT
Chapter 18 Radionuclide Therapy
18．1 Biological basis of radionuclide therapy
18．2 Treatment in hyperthyroidism with 131I
18．3 Treatment for solitary toxic nodule （Plummer's Disease） with 131I
18．4 Treatment for well-differentiated thyroid carcinoma with 1311
18．5 Radionuclide therapy of malignant bone metastases
18．6 32p Therapy in polycythemia vera and essential thrombocythemia
18．7 Radionuclide applicator therapy
Chapter 19 Role of ISF-FDG PET/CT in Pediatric Oncology
19．1 Brief introduction of pediatric malignant tumor
19．2 Clinical application of 18F-FDG PET/CT in pediatric malignant tumor
19．3 Radiation safety of 18F-FDG PET/CT in children
書單推薦
